🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

12 results for “AEON” Clear

  1. Paeoniflorin + phosphatidylcholine or silymarin

    China SXT Pharmaceuticals

    Hepatitis, Autoimmune

    phase 3 small molecule terminated

    1 trial

  2. ABP-450

    AEON Biopharma

    Cervical Dystonia

    phase 2 small molecule completed

    2 trials

  3. ABP-450

    AEON Biopharma

    Migraine

    phase 2 small molecule terminated

    2 trials

  4. Mitomycin C

    AEON Biopharma

    Glaucoma

    phase 2 small molecule completed

    1 trial

  5. Provisc

    AEON Biopharma

    Steroid Induced Glaucoma

    phase 2 small molecule completed

    1 trial

  6. ET1402L1-ARTEMIS™ T cells -IV

    AEON Biopharma

    Hepatocellular Carcinoma

    phase 1 mab completed

    1 trial

  7. Ologen Collagen Matrix

    AEON Biopharma

    Congenital Glaucoma

    phase 1 other active

    1 trial

  8. autologous ET1402L1-CART cells

    AEON Biopharma

    Hepatocellular Carcinoma

    phase 1 mab terminated

    1 trial

  9. Ursodeoxycholic acid combined with total glucosides of paeony

    China SXT Pharmaceuticals

    Hepatitis

    approved small molecule active

    1 trial

  10. Use of Mitomycin-C (MMC) in trabeculectomy

    AEON Biopharma

    Glaucoma

    approved small molecule completed

    1 trial

  11. Total glucosides of paeony & Acitretin Capsules

    First Tracks Biotherapeutics

    Psoriasis

    small molecule completed

    1 trial

  12. Use of Mitomycin-C in trabeculectomy

    AEON Biopharma

    Open-angle Glaucoma

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources